Cutera, Inc. (CUTR)
USD 0.1
(0.0%)
USD 0.1
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 431.91 Million USD | 0.3% |
| 2022 | 430.62 Million USD | 186.8% |
| 2021 | 150.14 Million USD | 491.24% |
| 2020 | 25.39 Million USD | 220.97% |
| 2019 | 7.91 Million USD | 1330.74% |
| 2018 | 553 Thousand USD | 20.22% |
| 2017 | 460 Thousand USD | -20.96% |
| 2016 | 582 Thousand USD | -0.34% |
| 2015 | 584 Thousand USD | -36.93% |
| 2014 | 926 Thousand USD | -29.53% |
| 2013 | 1.31 Million USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 434.17 Million USD | 0.52% |
| 2024 Q2 | 433.88 Million USD | -0.07% |
| 2023 Q4 | 431.91 Million USD | -0.01% |
| 2023 Q3 | 431.97 Million USD | 0.4% |
| 2023 Q2 | 430.23 Million USD | -0.03% |
| 2023 Q1 | 430.38 Million USD | -0.05% |
| 2023 FY | 431.91 Million USD | 0.3% |
| 2022 Q1 | 150.77 Million USD | 0.42% |
| 2022 Q2 | 314.93 Million USD | 108.88% |
| 2022 Q3 | 314.61 Million USD | -0.1% |
| 2022 Q4 | 430.62 Million USD | 36.87% |
| 2022 FY | 430.62 Million USD | 186.8% |
| 2021 Q3 | 150.86 Million USD | -0.04% |
| 2021 FY | 150.14 Million USD | 491.24% |
| 2021 Q4 | 150.14 Million USD | -0.48% |
| 2021 Q1 | 158.53 Million USD | 524.27% |
| 2021 Q2 | 150.92 Million USD | -4.8% |
| 2020 Q2 | 14.93 Million USD | 103.14% |
| 2020 Q4 | 25.39 Million USD | 0.49% |
| 2020 Q1 | 7.35 Million USD | -7.07% |
| 2020 FY | 25.39 Million USD | 220.97% |
| 2020 Q3 | 25.27 Million USD | 69.19% |
| 2019 Q4 | 7.91 Million USD | -7.16% |
| 2019 Q3 | 8.52 Million USD | -7.01% |
| 2019 Q2 | 9.16 Million USD | -4.53% |
| 2019 Q1 | 9.59 Million USD | 1635.8% |
| 2019 FY | 7.91 Million USD | 1330.74% |
| 2018 Q1 | 583 Thousand USD | 26.74% |
| 2018 Q3 | 640 Thousand USD | -3.76% |
| 2018 Q4 | 553 Thousand USD | -13.59% |
| 2018 FY | 553 Thousand USD | 20.22% |
| 2018 Q2 | 665 Thousand USD | 14.07% |
| 2017 Q2 | 604 Thousand USD | 6.9% |
| 2017 Q4 | 460 Thousand USD | -8.91% |
| 2017 FY | 460 Thousand USD | -20.96% |
| 2017 Q1 | 565 Thousand USD | -2.92% |
| 2017 Q3 | 505 Thousand USD | -16.39% |
| 2016 Q2 | 587 Thousand USD | 15.78% |
| 2016 FY | 582 Thousand USD | -0.34% |
| 2016 Q4 | 582 Thousand USD | -2.51% |
| 2016 Q3 | 597 Thousand USD | 1.7% |
| 2016 Q1 | 507 Thousand USD | -13.18% |
| 2015 FY | 584 Thousand USD | -36.93% |
| 2015 Q1 | 798 Thousand USD | -13.82% |
| 2015 Q2 | 699 Thousand USD | -12.41% |
| 2015 Q3 | 538 Thousand USD | -23.03% |
| 2015 Q4 | 584 Thousand USD | 8.55% |
| 2014 Q2 | 1.14 Million USD | -4.92% |
| 2014 FY | 926 Thousand USD | -29.53% |
| 2014 Q4 | 926 Thousand USD | -10.01% |
| 2014 Q3 | 1.02 Million USD | -9.82% |
| 2014 Q1 | 1.2 Million USD | -8.68% |
| 2013 FY | 1.31 Million USD | 0.0% |
| 2013 Q1 | 1.44 Million USD | 12.5% |
| 2013 Q3 | 1.35 Million USD | -2.38% |
| 2013 Q2 | 1.38 Million USD | -4.35% |
| 2013 Q4 | 1.31 Million USD | -2.88% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q4 | 1.28 Million USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| electroCore, Inc. | 626 Thousand USD | -68895.527% |
| NeuroPace, Inc. | 72.39 Million USD | -496.605% |
| Sight Sciences, Inc. | 35.41 Million USD | -1119.608% |
| TriSalus Life Sciences, Inc. | 1.59 Million USD | -26979.122% |
| SI-BONE, Inc. | 38.99 Million USD | -1007.694% |
| Anika Therapeutics, Inc. | 29.03 Million USD | -1387.454% |
| Accelerate Diagnostics, Inc. | 39.22 Million USD | -1001.254% |
| Cerus Corporation | 95.99 Million USD | -349.913% |
| Axonics, Inc. | 27.61 Million USD | -1463.935% |
| 908 Devices Inc. | 5.94 Million USD | -7165.13% |
| Treace Medical Concepts, Inc. | 70.3 Million USD | -514.358% |
| TELA Bio, Inc. | 42.78 Million USD | -909.612% |
| Venus Concept Inc. | 79.69 Million USD | -441.943% |
| Tivic Health Systems, Inc. | 369 Thousand USD | -116949.322% |
| RxSight, Inc. | 3.01 Million USD | -14239.708% |
| LENSAR, Inc. | 2.3 Million USD | -18605.587% |
| Rapid Micro Biosystems, Inc. | 7.34 Million USD | -5779.553% |
| LivaNova PLC | 640.4 Million USD | 32.556% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -18294.889% |
| Lucid Diagnostics Inc. | 15.25 Million USD | -2731.282% |
| Alphatec Holdings, Inc. | 541.67 Million USD | 20.264% |
| Apyx Medical Corporation | 38.5 Million USD | -1021.82% |
| STRATA Skin Sciences, Inc. | 15.63 Million USD | -2662.822% |
| BioSig Technologies, Inc. | 452 Thousand USD | -95455.752% |
| Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 74.317% |
| Bioventus Inc. | 409.47 Million USD | -5.479% |
| Envoy Medical, Inc. | 404 Thousand USD | -106808.911% |
| Helius Medical Technologies, Inc. | 57 Thousand USD | -757640.351% |
| Outset Medical, Inc. | 136.18 Million USD | -217.144% |
| Nexalin Technology, Inc. | 4463.00 USD | -9677515.953% |
| IRIDEX Corporation | 2.74 Million USD | -15628.769% |
| PROCEPT BioRobotics Corporation | 79.2 Million USD | -445.316% |
| IRadimed Corporation | 2.04 Million USD | -21040.622% |
| PAVmed Inc | 48.72 Million USD | -786.428% |
| INVO Bioscience, Inc. | 8.68 Million USD | -4873.904% |
| Movano Inc. | 252 Thousand USD | -171293.651% |
| Cytek Biosciences, Inc. | 33.17 Million USD | -1201.959% |
| NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -234125.597% |
| Spectral AI, Inc. | 1.28 Million USD | -33407.525% |
| Viemed Healthcare, Inc. | 10.27 Million USD | -4105.087% |
| Varex Imaging Corporation | 469.5 Million USD | 8.006% |
| Quipt Home Medical Corp. | 98.94 Million USD | -336.524% |
| IceCure Medical Ltd | 599 Thousand USD | -72005.509% |
| Pulmonx Corporation | 41.42 Million USD | -942.661% |
| Modular Medical, Inc. | 1.19 Million USD | -36195.126% |
| ReShape Lifesciences Inc. | 262 Thousand USD | -164751.908% |
| Insulet Corporation | 1.44 Billion USD | 70.188% |
| Semler Scientific, Inc. | 70 Thousand USD | -616917.143% |
| ClearPoint Neuro, Inc. | 13.94 Million USD | -2998.142% |
| Orthofix Medical Inc. | 134.19 Million USD | -221.844% |
| InMode Ltd. | 9.01 Million USD | -4689.974% |
| Bruker Corporation | 1.37 Billion USD | 68.693% |
| Surmodics, Inc. | 29.4 Million USD | -1368.839% |
| Cytosorbents Corporation | 18.31 Million USD | -2258.48% |
| iCAD, Inc. | 461 Thousand USD | -93590.239% |
| DexCom, Inc. | 2.59 Billion USD | 83.35% |
| Align Technology, Inc. | 96.96 Million USD | -345.417% |
| ZimVie Inc. | 521.92 Million USD | 17.247% |
| Nexalin Technology, Inc. | 4463.00 USD | -9677515.953% |
| DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | -21533.459% |
| BrainsWay Ltd. | 471 Thousand USD | -91601.062% |
| Tandem Diabetes Care, Inc. | 415.66 Million USD | -3.908% |
| Profound Medical Corp. | 7.9 Million USD | -5366.984% |
| enVVeno Medical Corporation | 1.4 Million USD | -30706.847% |
| Nuwellis, Inc. | 981 Thousand USD | -43927.727% |
| Nano-X Imaging Ltd. | 8.39 Million USD | -5044.259% |
| Aethlon Medical, Inc. | 940.31 Thousand USD | -45832.644% |
| Inogen, Inc. | 21.92 Million USD | -1870.132% |
| MaxCyte, Inc. | 18.74 Million USD | -2204.391% |
| iRhythm Technologies, Inc. | 129.82 Million USD | -232.69% |
| OrthoPediatrics Corp. | 23.76 Million USD | -1717.811% |
| DIH Holding US, Inc. Warrants | 1.99 Million USD | -21533.459% |
| InspireMD, Inc. | 1.59 Million USD | -26979.122% |
| PAVmed Inc. | 48.72 Million USD | -786.428% |
| Monogram Orthopaedics, Inc. | 491.99 Thousand USD | -87688.598% |
| BIOLASE, Inc. | 17.91 Million USD | -2311.569% |
| Beyond Air, Inc. | 17.83 Million USD | -2321.439% |
| FONAR Corporation | 41.67 Million USD | -936.36% |
| AxoGen, Inc. | 69.29 Million USD | -523.322% |
| Vivani Medical, Inc. | 20.69 Million USD | -1986.935% |
| Tactile Systems Technology, Inc. | 50.37 Million USD | -757.394% |
| Inari Medical, Inc. | 32.04 Million USD | -1247.746% |
| UFP Technologies, Inc. | 46.03 Million USD | -838.185% |
| QT Imaging Holdings, Inc. | 3.07 Million USD | -13963.93% |
| Heart Test Laboratories, Inc. | 1.03 Million USD | -41576.75% |
| Co-Diagnostics, Inc. | 2.99 Million USD | -14342.479% |
| Tenon Medical, Inc. | 1.17 Million USD | -36721.142% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -43004.99% |
| CVRx, Inc. | 30.61 Million USD | -1310.878% |
| AdaptHealth Corp. | 2.29 Billion USD | 81.177% |
| Sintx Technologies, Inc. | 4.24 Million USD | -10074.605% |
| Vivos Therapeutics, Inc. | 1.99 Million USD | -21549.724% |
| NanoVibronix, Inc. | 5000.00 USD | -8638140.0% |
| Quanterix Corporation | 41.46 Million USD | -941.655% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -18294.889% |
| Sensus Healthcare, Inc. | 783 Thousand USD | -55061.175% |
| Pacific Biosciences of California, Inc. | 933.93 Million USD | 53.753% |
| TransMedics Group, Inc. | 515.94 Million USD | 16.287% |
| ReWalk Robotics Ltd. | 1.9 Million USD | -22596.374% |
| NeuroMetrix, Inc. | 240.87 Thousand USD | -179208.856% |
| Hyperfine, Inc. | 185 Thousand USD | -233365.946% |
| Establishment Labs Holdings Inc. | 192.22 Million USD | -124.692% |
| Biomerica, Inc. | 785 Thousand USD | -54920.637% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -95990.842% |
| Bluejay Diagnostics, Inc. | 370.1 Thousand USD | -116599.855% |
| Silk Road Medical, Inc | 84.63 Million USD | -410.335% |